Directory
>
Mel Hayes
Mel Hayes
Chief Operating Officer | Fulcrum Therapeutics
Boston, Massachusetts, United States
Mel Hayes
Summary
Mel Hayes is a seasoned Executive Leader with over 25 years of experience in the biotechnology and pharmaceutical industries. Currently serving as the Chief Operating Officer at Fulcrum Therapeutics, Mel has a proven track record in corporate strategy, commercial operations, and product launch across multiple therapeutic areas including hematology, cardiology, and neurology. With an MBA from Columbia University, Mel combines strong business acumen with deep technical knowledge, having successfully managed top-line revenue of specialty businesses exceeding $1.5 billion. Mel is known for fostering purpose-driven cultures and building diverse teams that excel in cross-functional collaboration. His strategic insights have driven success in both U.S. and global markets, making him a key player in the commercialization of innovative therapies. Beyond his professional achievements, Mel is passionate about mentoring emerging leaders in the biotech sector and advancing healthcare accessibility.
Mel Hayes
Work Experience
Chief Operating Officer at
Fulcrum Therapeutics
July 2022 - Present
Chief Commercial Officer (CCO) at
Fulcrum Therapeutics
September 2021 - June 2022
Principal Owner at
HKH Consulting Company Limited
March 2020 - August 2021
Global Head, Vice President, Commercial Hemophilia & Complement, Rare Blood Disorders at
Sanofi
January 2019 - February 2020
Head, VP US & Global Commercial Strategic Marketing, Hematology, Complement Inline and Pipeline at
Bioverativ, a Sanofi company
October 2017 - January 2019
SVP, Head, Global Marketing and Launch Excellence at
SHIRE LIMITED
June 2016 - October 2016
Vice President, Global Inhibitors & Hemophilia B, Hematology at
Baxalta
July 2015 - June 2016
Vice President, Global Hemophilia Marketing, Inhibitors & Hemophilia B Portfolio at
Baxter International Inc.
January 2014 - June 2015
Senior Director Portfolio and LCM Management, Hematology at
Bayer AG
January 2008 - December 2013
Executive Director, Global Brand Team Head-Parkinsons at
Bayer AG
January 2005 - January 2008
Director, Global Strategy & EU Operations, Multiple Sclerosis at
Bayer AG
January 2002 - January 2005
Senior Product Manager, Diabetes Franchise at
Bristol Myers Squibb
January 1999 - January 2002
Area Marketing Manager at
Bristol Myers Squibb
January 1998 - January 1999
Senior District Manager, East Texas at
Bristol Myers Squibb
January 1995 - January 1997
Mel Hayes
Education
Columbia University - Columbia Business School, Mba
January 2001 - January 2003
Frequently Asked Questions about Mel Hayes
What is Mel Hayes email address?
Mel Hayes's primary email address is ******@fulcrumtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mel Hayes work for?
Mel Hayes is a Chief Operating Officer at Fulcrum Therapeutics, a company specializing in Commercial physical research.
Where Mel Hayes graduated from?
Mel Hayes holds a degree in General Managment, Finance, Marketing from Columbia University - Columbia Business School.
How can I directly contact Mel Hayes?
To contact Mel Hayes directly, you can use the email address ******@fulcrumtx.com. Complete contact information is available upon registration with Muraena.
Who is Mel Hayes?
Mel Hayes is a seasoned Executive Leader with over 25 years of experience in the biotechnology and pharmaceutical industries. Currently serving as the Chief Operating Officer at Fulcrum Therapeutics, Mel has a proven track record in corporate strategy, commercial operations, and product launch across multiple therapeutic areas including hematology, cardiology, and neurology. With an MBA from Columbia University, Mel combines strong business acumen with deep technical knowledge, having successfully managed top-line revenue of specialty businesses exceeding $1.5 billion. Mel is known for fostering purpose-driven cultures and building diverse teams that excel in cross-functional collaboration. His strategic insights have driven success in both U.S. and global markets, making him a key player in the commercialization of innovative therapies. Beyond his professional achievements, Mel is passionate about mentoring emerging leaders in the biotech sector and advancing healthcare accessibility.
Mel`s contact details
******@fulcrumtx.com
*********@bayer.com
*********@baxalta.com
Colleagues
Vice President, Head of Talent Acquisition & People Experience
Vice President, Head of Strategy & Program Lead
Chief Executive Officer
SVP, Head of Medical Affairs
Vice President
Vice President Drug Substance Process Development
Vice President, Head of Medicinal Chemistry
Chief Scientific Officer and Head of Technical Operations
Vice President Drug Safety & Pharmacovigilance
Chief Financial Officer